Medical FAQ’s

ActiveCare®+S.F.T. is a lightweight, mobile and battery-powered device that monitors the natural Venous Phasic Blood Flow and triggers a compression in sync with this flow. This unique patented Synchronized Flow Technology (S.F.T.) provides significant amplification to the venous flow pulsatility with only minor changes in the device’s impact on the legs, so providing gentle pressure, which delivers an optimal hemodynamic profile tailored to the patient’s specific physiology. The production of high blood flow speed and pulsatility generated by the device, its compact size, and the fact that it can be worn 24-hours a day, give it a definite advantage over standard competing products.
ActiveCare® fully meets ACCP 2012 Guidelines (CHEST)  for DVT prevention after Total Joint Replacement for the whole duration of treatment from hospital to home.
ActiveCare®+S.F.T.’s portability, ease of use, and quiet operation make it possible to be used on a 24-hour basis. In our studies, patients using ActiveCare®+S.F.T. achieved on average greater than 80% compliance, including in out-patient settings.
Although rare, such complications can also occur with ActiveCare®+S.F.T. Please give careful consideration to contraindications and check the skin under the sleeve at least once daily for signs of skin changes. In low risk patients the pneumatic sleeve should be removed once every 24 hours and the patient’s legs inspected. In high-risk patients (elderly, unconscious, paralyzed, or with severe known peripheral neuropathy or with continuous epidural analgesia) the legs should be inspected every eight hours. It is important to fit the correct sleeve size to the patient’s leg. Sleeves can also be worn on top of simple cotton stockinettes, rather than worn directly on the skin.
The combination of stationary IPC with a GCS, achieves better results in DVT prevention when compared to IPC alone. Although the addition of a GCS does not increase PVV (Peak Velocity), it is thought to add a “second line” of defense to traditional stationary IPC devices, especially when the stationary devices are not used.

However, unlike the standard stationary IPCs, with ActiveCare®+S.F.T., a GCS is not required in conjunction with the device, due to its high patient compliance. The outstanding clinical results of the ActiveCare®+S.F.T. in DVT prevention were all achieved with calf sleeves only and without an additional GCS.

We recommend using calf sleeves because of the high peak venous velocity that they achieve at the common femoral vein and because they facilitate compliance level in and out of the hospital. Foot sleeves are recommended only in situations where calf or thigh sleeves cannot be used.
The ActiveCare®+S.F.T. device provides 50mmHg of pressure to the patient’s limb with the calf and thigh sleeves, and 130 mmHg with the foot sleeves.
No. The medical world is rapidly moving towards mobile devices. Other small and portable devices are routinely used in hospitals (portable monitors, IVACs, telemetry, etc.); small size and portability are considered an advantage rather than a disadvantage.
The AC/DC adaptor is medical grade and is FDA approved . It holds a TUV, UL 60601-1 and ISO 1348:2003 approvals as well. The requirement for three pins usually applies to metal covered devices. Moreover, the use of the three pins connector is actually forbidden for use in devices that have double insulation (UL 60601-1).
The carrying strap is not “permanent”. It was designed to be easily detached for cleaning or sterilization and can be replaced. The strap is made of a nylon material which doesn’t absorb fluids. For daily maintenance it can be easily cleaned with 70% alcohol.
There are 2 lengths of tubing available. Long tubing, 6.6 ft (2 meters), are for use in the OR. Short tubing, 3.9 ft (1.2 meters), are for use in the rehab nursing unit. The shorter tubing is generally used to allow for patient mobility and comfort.